This page is specifically intended to support patients who have been prescribed Aimovig (erenumab) by a UK healthcare provider. If you have any questions about your medication, ask your doctor, nurse or pharmacist and read the patient information leaflet provided with your medicine.
Patient resources
A guide for patients prescribed Aimovig to provide them with important information about what Aimovig is, who it is for, how it works and what to expect during treatment.
These links will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.
GB patient Information Leaflet (PIL) for Aimovig
GB Summary of Product Characteristics (SmPC) for Aimovig
These links will take you to the electronic medicines compendium (emc) Northern Ireland website, which is a non-Novartis website.
NI Patient Information Leaflet (PIL) for Aimovig
NI Summary of Product Characteristics (SmPC) for Aimovig
UK | October 2024 | 449338
Reporting side-effects
If you get side-effects with any medication you are taking, talk to your doctor, pharmacist or nurse. This includes any possible side-effects not listed in the information leaflet that comes in the pack. You can report side-effects via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
By reporting side-effects you can help provide more information on the safety of your medication.